Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2001
02/06/2001US6184254 Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors
02/06/2001US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity
02/06/2001US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy
02/06/2001US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax
02/06/2001US6184182 Plant treatment composition that comprises an exogenous chemical and an alkylether surfactant or mixture of such surfactants
02/06/2001US6184043 Monitoring and counting preferential aggregations in suspension; coat paramagnetic particles or beads with antibody, mix coated particles with preferential aggregates, incubate, monitor and count aggregations after incubation
02/06/2001US6184042 Method for reducing hook effect in an immunoassay
02/06/2001US6184039 Method for determining the fat content of feed, food, and other materials utilizing filter media encapsulation
02/06/2001US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells
02/06/2001US6184030 Biologically-active polymers
02/06/2001US6184027 Recovering, isolating and purifying eubacteria or fungus from sample; incubate sample with deactivated protein which is bound to solid phase matrix, wash, isolate and recover purified microorganisms
02/06/2001US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases
02/06/2001US6184022 Membrame matrix enzymatic protein; for use in the diagnosis and of tumors
02/06/2001US6184013 Antibody for reducing concentration of drug in patient
02/06/2001US6183990 Compounds
02/06/2001US6183986 OspA DNA and lyme disease vaccine
02/06/2001US6183981 Diagnostic assay for late-onset Alzheimer's disease
02/06/2001US6183980 Method for locating defects in the clotting system
02/06/2001US6183979 Mixing recombinant fusion protein of bacterial thioredoxin and rabbit brain tissue factor with mixture of synthetic phospholipids to activate protein, then air drying above 10 degrees celsius; storage stable at 37 degrees celsius
02/06/2001US6183977 Determining hepatic status of a liver transplant recipient by measuring PI glutathione S-transferase
02/06/2001US6183975 Method of detection of congenital disease
02/06/2001US6183974 Transfecting specific cells which express urokinase plasminogen activator and have suppressed gs signaling of enzyme with expression vector coding for g protein coupled receptor, contacting with compound, measuring enzyme activity
02/06/2001US6183972 Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect
02/06/2001US6183970 Polynucleotide probe chip and polynucleotide detection method
02/06/2001US6183965 Modulating expression of target gene in recombinant cell using low molecular weight (less than 5 kilodaltons), membrane permeable compounds
02/06/2001US6183962 Nucleotide sequence of cardiovascular system associated protein kinase; antisense agents; recombinant expression vectors; host cells for culture production; diagnosis and treatment of cardiovascular disorders; probes; primers; kits
02/06/2001US6183954 Method for evaluating the metastatic tendency of tumors
02/06/2001US6183951 Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy
02/06/2001US6183950 Method and apparatus for detecting viruses using primary and secondary biomarkers
02/06/2001US6183949 HCV peptide antigens and methods for the determination of HCV
02/06/2001US6183948 Methods to identify compounds affecting mitochondria
02/06/2001US6183772 Doped liposomes comprise: a) a plurality of polymerized diynes; b) one or more ligands having an affinity for said analyte; and c) a dopant having no affinity for said analyte.
02/06/2001US6183755 These proteins can be used to produce specific and sensitive diagnostic assay kits. the specific combination of the immunologically active proteins makes precise diagnosis possible.
02/06/2001US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies
02/06/2001US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof
02/06/2001US6183695 Reactor utilizing hydrogen absorption in combination with photolysis and/or electrolysis of organic compounds for in situ generation of carbon dioxide; accurate determination of even low levels of carbon compounds in aqueous samples
02/06/2001US6183694 Spectrophotometric apparatus for reducing fluid carryover
02/06/2001US6183651 Blood processing systems and methods which optically monitor plasma opacity
02/06/2001US6183635 Hydrocarbon class separation and quantitation by split column effluent analysis
02/06/2001US6183418 Process and measuring system for detection of substances emitted or perspired through the skin
02/06/2001US6183416 Diagnostic method for inflammatory conditions in the intestines
02/06/2001US6183128 Apparatus and method for determining paperboard thermal conductivity
02/06/2001US6183121 Computer for producing a three-dimensional representation of a molecule or complex of a binding pocket of given structure coordinates and amino acid residues; computer model for designing possible antagonists or agonists of helicase
02/06/2001US6182665 Maternal immune responsiveness as a predictor of pregnancy outcome
02/06/2001US6182505 Method and apparatus for studying the properties of a multiphase fluid under pressure flowing in a duct, such as a petroleum stream
02/06/2001US6182504 Emulsion composition monitor
02/06/2001US6182503 On-line rheological measurement for process control
02/06/2001US6182500 Gas sensor with protective gate, method of forming the sensor, and method of sensing
02/06/2001US6182499 Systems and methods for characterization of materials and combinatorial libraries with mechanical oscillators
02/06/2001US6182497 Gas detection system and method
02/06/2001CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography
02/06/2001CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
02/06/2001CA2210766C Apparatus and methods for the analysis of trace constituents in gases
02/06/2001CA2207307C Compounds and methods for monosaccharide analysis
02/06/2001CA2181190C Mesoscale sample preparation device and systems for determination and processing of analytes
02/06/2001CA2172144C Hapten-marked peptides
02/06/2001CA2130947C Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents
02/06/2001CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor
02/06/2001CA2028789C Kinetic assay for endotoxin using limulus amebocyte lysate and chromogenic substrate
02/06/2001CA2013544C Retinoblastoma gene product antibodies and uses therefor
02/03/2001CA2314466A1 Lentivirus from the group of immunodeficiency viruses of drill monkeys (mandrillus leucophaeus) and their use
02/01/2001WO2001008081A1 System for microvolume laser scanning cytometry
02/01/2001WO2001007921A2 Stabilized coagulation control reagent
02/01/2001WO2001007919A1 Method for examining substance interacting with hormone receptor
02/01/2001WO2001007918A1 Catalytic anti-factor viii allo-antibodies
02/01/2001WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients
02/01/2001WO2001007916A1 Method for diagnosing diseases and pathological states
02/01/2001WO2001007915A2 Layered device with capture regions for cellular analysis
02/01/2001WO2001007913A1 Method for immunologically analyzing and assaying environmental pollutant
02/01/2001WO2001007912A2 Immunoassay for pesticides and their degradation products
02/01/2001WO2001007911A2 A novel method for the improved isolation of a target cell population
02/01/2001WO2001007910A1 Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility
02/01/2001WO2001007909A1 Electromagnetic analyzer of anisotropy in chemical organized systems
02/01/2001WO2001007907A1 Food applications of artificial olfactometry
02/01/2001WO2001007904A1 Method and apparatus for reducing peak broadening associated with the establishment of an electric field
02/01/2001WO2001007903A2 Gas sensor with phased heaters for increased sensitivity
02/01/2001WO2001007898A1 Micro-array information display method
02/01/2001WO2001007896A1 Luminescence detection workstation
02/01/2001WO2001007892A1 Method and device for measurement of cholesterol efflux
02/01/2001WO2001007891A2 Miniaturized cell array methods and apparatus for cell-based screening
02/01/2001WO2001007890A2 A method of controlling the temperature of a specimen in or on a solid support member
02/01/2001WO2001007889A2 Miniaturized cell array methods and apparatus for cell-based screening
02/01/2001WO2001007874A1 Methods and devices for measuring interface levels between fluids, and uses thereof
02/01/2001WO2001007665A2 Sequence determination of nucleic acids using electronic detection
02/01/2001WO2001007661A2 Polynucleotide amplification method
02/01/2001WO2001007659A2 Methods for identifying inhibitors of signaling molecules
02/01/2001WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies
02/01/2001WO2001007654A1 Method for identifying compounds which modulate circadian rhythm
02/01/2001WO2001007653A1 Spatially-encoded analyte detection
02/01/2001WO2001007647A2 Method for relative quantization of methylation of cytosin-type bases in dna samples
02/01/2001WO2001007642A1 Computer-assisted formulation of culture media
02/01/2001WO2001007638A2 Homogeneous fluorescence method for assaying structural modifications of biomolecules
02/01/2001WO2001007628A2 Human synthetases
02/01/2001WO2001007625A2 Ehrlichia canis genes and vaccines
02/01/2001WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis
02/01/2001WO2001007612A2 Receptors and associated proteins
02/01/2001WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY
02/01/2001WO2001007604A1 Isolated peptide of the horny layer and use thereof
02/01/2001WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same
02/01/2001WO2001007585A1 Electrical impedance tomography to control electroporation